Varenicline / varenicline

Varenicline / varenicline is an active ingredient that is used in some medicines.

The active ingredient is the chemical in a medicine that makes it work. Medicines can have more than one active ingredient and be available under different brand names. Medicines include both active ingredients and inactive ingredients.

This page about varenicline / varenicline automatically lists related information collected from other pages of our website.

The list below also includes links to brands of medicines that contain varenicline / varenicline, including their consumer medicine information (CMI) leaflets.

Consumers: If you have any questions about medicines, you can speak to one of our pharmacists at NPS Medicines Line by calling 1300 633 424. You can ring Monday to Friday, 9 am to 5 pm, Australian Eastern Standard Time (excluding NSW public holidays). For non-medicine products, further information may also be available from the manufacturer.

Related information - varenicline / varenicline

Audience:
       

(Medicine)
12 Oct 2016 Champix Combination pack is a brand of medicine containing the active ingredient varenicline tartrate / varenicline tartrate. Find out about side effects, who can take it and who shouldn’t use Champix Combination pack by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
(Medicine)
12 Oct 2016 Champix Tablets is a brand of medicine containing the active ingredient varenicline tartrate. Find out about side effects, who can take it and who shouldn’t use Champix Tablets by reading the latest Australian consumer medicine information, plus tips on how to use medicines wisely and safely.
For health professionals (Health professional publication)
10 Apr 2015 Although NMR testing is not yet used in Australian general practice, it holds promise for informing choice of smoking cessation pharmacotherapies in the future. Read more.
For health professionals (Health professional publication)
01 Dec 2014 From 1 October 2014 the note to the PBS listing for varenicline tartrate has changed to permit another course of varenicline (instead of buproprion) in patients who did not stop smoking after an initial 12- or 24-week treatment course, provided that 6 months have elapsed between starting the previous course of varenicline and the subsequent course.
(Consumer publication)
03 Nov 2014 Find out what varenicline does, its side effects, and how it compares with other medicines for quitting. Find out about ways to quit without medicines too.
For health professionals (Health professional publication)
14 Aug 2013 A new meta-analysis of pharmacological interventions for smoking cessation (nicotine replacement therapy, varenicline and bupropion) suggests some treatments are better than others.
For health professionals (Health professional publication)
16 Jan 2013 Meta-analysis indicates a small, statistically non-significant increase in cardiovascular events with varenicline. Weigh the risk against health benefits of quitting.
For health professionals (Health professional publication)
01 Aug 2011 Review of varenicline (Champix) for smoking cessation, including adverse effects, treatment efficacy, and drug interactions.
(Media release)
20 Jul 2011 New research linking an anti-smoking medicine to an increased risk of heart attacks remains uncertain. Anyone with concerns about taking the medicine should talk to their health professional or seek more information, according to NPS MedicineWise
(Media release)
20 Jul 2011 Uncertainty remains despite new research published this month linking a smoking-cessation medicine to an increased risk of heart attacks, according to NPS

Medicine brands that contain varenicline / varenicline